Commerce Secretary Howard Lutnick has been putting the squeeze on companies and trading partners in an unusual effort to ...

Esperion's stock surged over 30% this month after Q2 results beat expectations, driven by strong U.S. sales and global ...

NearPoint Strategies’ ground breaking new programme launches to help executives and B2B sales teams turn LinkedIn into a ...

PGIM shares how the Jennison Health Sciences Fund weathered Q2 volatility by leaning into undervalued innovators. Discover ...

Pharmacy leaders are facing high-stakes challenges that could threaten the stability of drug access and affordability across the U.S. Amid this uncertainty, health systems are responding with urgency, ...

House of McQueen ought to be dripping in blood and exposed vertebrae. Instead, it’s all taupe with a relaxed fit.

More than 45 heads of state are attending this edition, which organisers say will be “marked by determination rather than rhetoric.” ...

A report from the White House outlines strategies to combat childhood chronic disease and attempts to set a MAHA agenda for the country.

The mindset shift for leaders aiming at the C-suite is moving from "I want to be liked" to "I want to be respectful and also ...

Wealth Enhancement reports that rising tariffs are increasing consumer prices, straining budgets, and impacting investments ...

Discover the best natural anti-inflammatories in 2025 that help reduce pain, calm inflammation, and support long-term ...

Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational treatment for Multiple System Atrophy (MSA) in Phase 2 development.New th ...